Purchase Order 75N94021P00801
- Not listed
- This is a $19,386.28 firm fixed-price purchase order awarded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency under the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for assaying services to support NIAAA's research activities, with a completion date of August 27, 2024. Eurofins Discoverx Corporation is a provider of cell-based assays, reagents, and services for drug...
- This is a federal contract award from the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for $301,894.16 in firm fixed-price services related to testing lead compounds for additional characterization and reagent development. The contract does not have a set-aside designation. Eurofins Discoverx Corporation is a provider of innovative cell-based...
- The National Institute on Alcohol Abuse and Alcoholism awarded a Blanket Purchase Agreement (BPA) call contract valued at $3,741.00 to Eurofins Discoverx LLC on November 4, 2016, with completion scheduled for November 3, 2017. This firm fixed-price contract was awarded without set-asides and is to be performed in Bethesda, Maryland. Eurofins Discoverx LLC, a foreign-owned biotech firm specializing in cell-based assays and research reagents, has been registered to receive federal awards since...
- The National Institute on Alcohol Abuse and Alcoholism (NIAAA) awarded a $16,058.50 firm fixed price BPA call contract to Eurofins Discoverx LLC for laboratory testing services. Awarded on June 22, 2017, with an ultimate completion date of September 30, 2017, this contract was issued without a set-aside designation. The work is to be performed in Rockville, Maryland, where NIAAA maintains its headquarters. Eurofins Discoverx LLC, a foreign-owned, for-profit organization specializing in...
- This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, is for the provision of specialized cell-based assays, reagents, and services to support drug discovery and research. The $13,482.10 firm fixed-price purchase order was awarded by the Midwest Area of the U.S. Department of Health and Human Services, which includes agencies such as the National Institutes of Health (NIH). The contract is for the delivery of PathHunter HTR2A GPCR internalization...
- This federal contract award was issued by the National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services. The $22,869.00 firm fixed-price purchase order was awarded to Eurofins Discoverx LLC, a foreign-owned for-profit organization that specializes in providing cell-based assays, reagents, and services to support drug discovery and development research. The purpose of this contract is to conduct a kinase panel screening of 25 small...
- The federal contract award is for $300,609.00 and was granted to Eurofins Discovery Services North America, LLC, a foreign-owned, for-profit contract research organization. The award is a delivery order under a larger indefinite delivery vehicle (IDV) contract with the National Institute on Drug Abuse (NIDA), a part of the U.S. Department of Health and Human Services. The contract is for receptor profiling and predictive toxicology services, specifically receptor binding studies, safety...
- This federal contract award to Eurofins Discoverx Corporation, a foreign-owned for-profit organization, was issued by the National Institute on Drug Abuse (NIDA), a component of the U.S. Department of Health and Human Services. The $26,769.20 firm fixed-price purchase order is for the provision of PathHunter detection kit reagent, item #93-0001L, to support the HEAL (Helping to End Addiction Long-term) initiative's medicinal chemistry research to improve potency and selectivity of dopamine...
- This is a federal contract award from the National Center for Advancing Translational Sciences (NCATS), part of the National Institutes of Health (NIH), to Eurofins Discoverx LLC, a foreign-owned for-profit organization based in Fremont, California. The contract, which does not have a set-aside designation, is for stable cell line screening services to support compound discovery research. The fixed-price contract has a ceiling value of $24,985.40 and an ultimate completion date of December 30,...
- The Department of Health and Human Services National Institutes of Health National Center for Advancing Translational Sciences (NCATS) awarded a firm-fixed-price purchase order valued at $20,787.00 to Eurofins Discoverx Corporation, a foreign-owned for-profit organization. The contract is for the provision of the PATHHUNTER CHO-K1 DRD2L (LONG ISOFORM) ARRESTIN cell line, which is used in drug discovery and development research. Eurofins Discoverx is a leading provider of innovative cell-based...
This federal contract award, valued at $17,895.60, was issued by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), a civilian agency within the U.S. Department of Health and Human Services, to Eurofins Discoverx Corporation, a foreign-owned, for-profit organization. The contract was awarded on a firm fixed-price basis without any set-aside designations. Eurofins Discoverx Corporation, which specializes in providing innovative cell-based assays, reagents, and services to support drug discovery and development research, will deliver unspecified products or services related to DISCOVERX:1110212 [21-002839]. The company has an extensive history of securing federal contracts and grants, particularly with agencies focused on alcohol abuse research, drug abuse studies, and infectious disease research, such as the National Institute of Neurological Disorders and Stroke, National Institute on Drug Abuse, and the Defense Health Agency.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.9k | 8/30/21 |